Premium
Outreach monitoring service for patients with indolent B‐cell and plasma cell disorders: a UK experience
Author(s) -
Rawstron Andy C.,
Jones Richard A.,
Ferguson Carol,
Hughes Geraint,
Selby Pam,
Reid Carol,
Dalal Surita,
Howard Martin,
Smith Graeme,
Hillmen Peter,
Owen Roger G.,
Jack Andrew S.
Publication year - 2007
Publication title -
british journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.907
H-Index - 186
eISSN - 1365-2141
pISSN - 0007-1048
DOI - 10.1111/j.1365-2141.2007.06864.x
Subject(s) - medicine , phlebotomy , hematology , lymphocytosis , outreach , disease , chronic lymphocytic leukemia , intensive care medicine , pediatrics , leukemia , political science , law
Summary Disease progression occurs in over 1% of monoclonal gammopathy of undetermined significance, monoclonal B‐cell lymphocytosis and early stage chronic lymphocytic leukaemia patients every year therefore regular monitoring is indicated. We assessed the efficacy of an outreach service to replace clinic monitoring using local phlebotomy with central haematologist review of laboratory parameters and symptoms identified by a patient self‐assessment questionnaire. The service was used by 299 patients for 2 years and provided accurate monitoring, improved patient satisfaction, support for primary care and reduced the burden on haematology clinics without an increase in inter‐assessment admissions due to disease progression.